Wyden and Brown Urge FTC to Investigate Emerging Anti-Competitive Practices by PBMs
As Congress and FTC Continue to Investigate and Address the Role of Pharma Middlemen in High Drug Costs, Leading Senators Highlight...
top of page
News
Oct 1
A Free Drug Experiment Bypasses the US Health System’s Secret Fees
A top California health plan is set to offer one of the world’s biggest-selling drugs for free in a bid to show the medicine can reach...
Oct 1
PBM Accountability Project Statement on Governor Newsom Veto of SB 966
California Governor Gavin Newsom (D) has vetoed CA SB966 , legislation which would increase transparency and accountability of pharmacy...
Sep 25
It’s Time For The Truth On The High Cost Of Drugs
Make no mistake , our medicines, like everything else these days, cost far more than they should. Rather than acknowledging the actual...
Sep 23
PBM Accountability Project Statement on FTC Legal Action Against “The Big 3” PBMs
The Federal Trade Commission last week filed a suit accusing the three largest pharmacy benefit managers, or PBMs, of using their market...
Sep 20
FTC sues pharmacy insurance managers, alleging unfair drug prices
The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of...
Sep 20
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin...
Sep 11
Medicare’s addiction to disconnected drug prices
Prescription drug prices in the U.S. receive a lot of attention. Some of it is academic, such as comparisons amongst how we measure drug...
Sep 10
New AMA analysis of consolidation in PBM markets
The American Medical Association (AMA) today published its new annual analysis (PDF) of pharmacy benefit manager (PBM) markets...
Sep 6
Pharmacy Benefit Managers: Not Campaign Fodder So Far. But the Push for Reform May Be Gaining Traction
It is a safe bet that pharmacy benefit managers (PBMs) aren’t going to become a big issue in the presidential election. PBMs are still...
Aug 24
The Biden-Harris Administration Must Side With Patients Against Big Insurers' Illegal Greed
President Joe Biden, Vice President Kamala Harris, and U.S. Department of Health and Human Services Secretary Xavier Becerra have a...
Aug 19
PBMs are Misleading America
As Congress investigates the pharmacy benefit manager (PBM) problem, these middlemen corporations continue steering patients away from...
Aug 16
Parties Agree — Lawmakers Need to Stop Drug Price Manipulation
The evidence against pharmacy benefit managers, or PBMs, has been piling up. Congress and multiple state legislatures have held hearings...
Aug 8
Untangling The $500 Billion PBM Web: The Opaque Relationship Between Employers And Drug Middlemen
On the heels of the FTC’s investigation into pharmacy benefit managers for what many regard as anti-competitive business practices, legal...
Aug 1
National Poll of Likely 2024 Voters Shows Strong Bipartisan Support for Specific PBM Reform Policies and Candidates Who Support Them
Likely Voters Want Policies to Require PBM Middlemen to Provide Value, Lower Out-of-Pocket Prescription Drug Costs Washington, DC – On...
Jul 26
Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?
Pharmacy middlemen known as pharmacy benefit managers deny claims that they’re responsible for the inflating cost of medicine. They say...
Jul 23
PBM Accountability Project Members Host Important PBM Discussion on Capitol Hill
On Wednesday, July 9, the National Community Pharmacists Association (NCPA) and Coalition of State Rheumatology Organizations (CSRO) –...
Jul 23
House hearing keeps pressure on PBM practices while Congress considers reforms
The hearing keeps attention on PBM reforms as Congress nears the period between elections in November and when newly elected officials...
Jul 23
Medication middlemen face bipartisan criticism as Congress eyes industry reforms
Executives from three of the largest pharmacy benefit managers (PBMs) pushed back against bipartisan criticism during a House Oversight...
Jul 10
PBM Accountability Project Statement on FTC Interim Report on PBMs
The Federal Trade Commission on July 9 issued its interim report on prescription drug middlemen known as pharmacy benefit managers or...
Jul 9
F.T.C. Says Middlemen Appear to Be Driving Up Drug Prices
In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing...
Jul 9
Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says
Investigation finds firms, which are supposed to control spending, have overcharged for cancer drugs and taken other steps raising costs...
Jul 9
FTC report finds PBMs profit at the expense of patients and independent pharmacies
In stark terms, the Federal Trade Commission found in a report released Tuesday that pharmacy benefit managers — the opaque middlemen in...
Jun 25
Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.
One employer was paying about $100 for a prescription for a generic antidepressant, though it could be bought elsewhere for about $12 A...
bottom of page